Official announcements, media coverage, and our presence at international congresses and exhibitions.
Official statements written by EndoRobotics, published here in full.
Olympus will exclusively distribute EndoRobotics' robot-assisted endoscopic technologies worldwide as part of its EndoTherapy portfolio, beginning in the United States.
Read full release ›The U.S. FDA has cleared EndoRobotics' ROBOPERA™ endoscopic surgical robot, making EndoRobotics the first Korean medical device company to receive a clearance under the FDA's 'NAY' product code — the classification used for robotic systems, including Intuitive Surgical's da Vinci, that actively perform endoscopic and laparoscopic interventions.
Read full release ›Media coverage links to articles published by third-party outlets. Headlines and articles remain the property of their respective publishers; links open the original source.
EndoRobotics received the Minister of Trade, Industry and Energy Award at Startup Nation Korea (SNK) 2026, and presented ROBOPERA™ and EndoCubot™ to attendees at Seoul National University.
Read more ›
Highlights from Booth No. 18 at ESGE Days 2026 in Milan — hands-on demonstrations of the robotic traction platform and the EndoCUP challenge on the EndoCubot™ simulator.
Read more ›
Highlights from Booth No. 5046 at Digestive Disease Week — hands-on demonstrations of the ROBOPERA™ x TraCloser™ platform and the second EndoCUP challenge on the EndoCubot™ simulator.
Read more ›
EndoRobotics joined Cedars-Sinai's inaugural Future of Endoscopy Summit as the only Korean company on the panel, then ran a booth and a live ROBOPERA™ demonstration at the 2026 International Endoscopy Symposium in Los Angeles.
Read more ›
Contact us